Galenica AG

Equities

GALE

CH0360674466

Pharmaceuticals

Real-time Estimate Cboe Europe 08:20:32 2024-04-24 am EDT 5-day change 1st Jan Change
71 CHF +0.50% Intraday chart for Galenica AG +2.23% -2.41%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Switzerland's Galenica Issues CHF100 Million Bond Due 2031 MT
GALENICA : FY23 one-offs shroud decent underlying profitability growth Alphavalue
Swiss Stocks Shrug Off Sticky US Inflation Report MT
Galenica AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Galenica AG, 2023 Earnings Call, Mar 12, 2024
Galenica Posts Rise in FY23 Attributable Profit, Sales MT
Galenica AG acquired 33% stake in Farmadomo Home Care Provider SA. CI
GALENICA : In-line FY23 sales validate our cautious stance Alphavalue
Global markets live: Flutter, Humana, Bayer, KKR, Boeing... Our Logo
Galenica Posts Rise in FY23 Sales; Dividend Outlook Affirmed MT
Research Partners Lifts Price Target on Galenica, Maintains Hold Recommendation MT
GALENICA : H1 23: Broad-based top-line momentum, underlying EBIT trends unchanged Alphavalue
Global markets live: Abrdn, Beyond Meat, Novavax, Under Armour, Lucid... Our Logo
Transcript : Galenica AG, H1 2023 Earnings Call, Aug 08, 2023
Galenica AG Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Galenica Records Gain in H1 Profit, Sales MT
Redcare Pharmacy raises revenue and margin forecast DP
Galenica to Buy 16% Stake in E-health Provider AD Swiss MT
Galenica AG acquired AD Swiss Net AG. CI
Shop Apotheke Europe Receives Regulatory Nod for Galenica JV MT
Strong start to the year for Shop Apotheke - Board of Management confirms targets DP
Transcript : Galenica AG, Shop Apotheke Europe N.V. - Shareholder/Analyst Call
GALENICA : Light FY 22 earnings and a soft FY 23 outlook disappoint investors Alphavalue
Transcript : Galenica AG, 2022 Earnings Call, Mar 07, 2023
Galenica Posts Lower FY22 Attributable Net Profit MT
Chart Galenica AG
More charts
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
70.65 CHF
Average target price
76.25 CHF
Spread / Average Target
+7.93%
Consensus
  1. Stock Market
  2. Equities
  3. GALE Stock
  4. News Galenica AG
  5. Galenica Sells Medical Products Unit Careproduct